Mechanisms of human papillomavirus E6/E7 expression during cellular differentialtion of cervical cancer
人乳头瘤病毒E6/E7表达在宫颈癌细胞分化过程中的机制
基本信息
- 批准号:08671876
- 负责人:
- 金额:$ 1.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To clarify the molecular mechanisms through which human papillomavirus E6/E7 expression is activated during the process of cellular differentiation in stratified epithelial cells of uterine cervix, we identified core enhancer of upstream regulatory region of HPV3 1 b E6/E7 genes using transient expression assays. DNA foot print analyses and gel shift analyses identified sevral nuclear factors which bind core enhancer and regulate transcription of E6/E7 genes. In particular, Ap1 was found to be the most potent transactivator. In situ hybridization analyses revealed that E6/E7 mRNA was expressed mainly in the undifferentiated basal layers of stratified epithelial cells in uterine cervix, which was co-localized with AP1 expression determined by immunohistochemical analyses. These findings suggest that AP1 is the critical determinant of HPV oncogene expression. In addition, we found that cellular factor YY1 cooperates with API to achieve full activation of HPV oncogene expression. These results may provide insight into molecular targets for gene therapies against cervical cancer induced by HPV infection.
为阐明人乳头瘤病毒E6/E7基因在子宫颈上皮细胞分化过程中表达激活的分子机制,我们采用瞬时表达分析法鉴定了HPV 3 1 B E6/E7基因上游调控区的核心增强子。DNA足迹分析和凝胶位移分析鉴定了与核心增强子结合并调控E6/E7基因转录的几种核因子。特别是,发现Ap 1是最有效的反式激活因子。原位杂交结果显示,E6/E7 mRNA主要表达于子宫颈复层上皮细胞未分化的基底层,与免疫组化结果显示的AP 1表达共定位。这些结果表明,AP 1是HPV癌基因表达的关键决定因素。此外,我们发现细胞因子YY 1与API协同作用,实现HPV癌基因表达的完全激活。这些结果可能为HPV感染诱导的宫颈癌基因治疗提供分子靶点。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Satoru Kyo,David Masaki Inoue.et al: "Expression of AP1 during cellnlan differentiation determines human papillomarims E6/E7 expression in stratified epithelal all" Journal of General Virology. 78. 401-411 (1997)
Satoru Kyo、David Masaki Inoue.et al:“cellnlan 分化过程中 AP1 的表达决定了分层上皮细胞中人乳头状瘤 E6/E7 的表达”《普通病毒学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
"The 5'Region of the Human Papillomavirus Type 31 Upstream Regulatory Region Acts as an Enhancer which Augments Viral Early Expression Thrugh the Action of YY1" Virology. 237. 159-169 (1997)
“人乳头瘤病毒 31 型上游调节区的 5 区域充当增强子,通过 YY1 的作用增强病毒早期表达”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tan Kanaya, Satoru Kyo Laimins A reimonis: "The 5' region of the human porpilloma Virus type 31 upstream rignlatory region acts as an enbehave which Angments viral early expression" Virology. 237. 159-169 (1997)
Tan Kanaya、Satoru Kyo Laimins A reimonis:“人孔雀瘤病毒 31 型上游的 5 区域充当了影响病毒早期表达的行为”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kyo.S et al: "Transcrptional activity of HPV31b enhancer is regultaed through synergistic interaction of AP1 with two novel factor" Virology. 211. 184-197 (1995)
Kyo.S 等人:“HPV31b 增强子的转录活性是通过 AP1 与两个新因子的协同相互作用来调节的”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KYO Satoru其他文献
KYO Satoru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KYO Satoru', 18)}}的其他基金
Exploration of molecular targets for endometriosis-associated ovarian cancer with in vitro multistep carcinogenesis model
体外多步致癌模型探索子宫内膜异位症相关卵巢癌的分子靶点
- 批准号:
23390387 - 财政年份:2011
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of molecular mechanisms and the targets using in vitro carcinogenesis model of endometrial cancer.
使用子宫内膜癌体外致癌模型鉴定分子机制和靶点。
- 批准号:
20390432 - 财政年份:2008
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of novel cancer therapy using telomerase-specific replication competent adenovirus
使用具有端粒酶特异性复制能力的腺病毒建立新型癌症疗法
- 批准号:
17390449 - 财政年份:2005
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of novel molecular cancer therapy targeting telomerase and its clinical appication to gynecologic tumors
端粒酶靶向肿瘤新疗法的建立及其在妇科肿瘤中的临床应用
- 批准号:
15390501 - 财政年份:2003
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of novel gene therapy targeting gynecologic tumors
针对妇科肿瘤的新型基因疗法的建立
- 批准号:
13557138 - 财政年份:2001
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of telomerase-based novel gene therapy and diagnosis for gynecologic tumors
基于端粒酶的妇科肿瘤新型基因治疗与诊断的建立
- 批准号:
13671702 - 财政年份:2001
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Detection of telomerase activity and hTERT mRNA expression and its application for the diagnosis of gynecologic tumors
端粒酶活性和hTERT mRNA表达检测及其在妇科肿瘤诊断中的应用
- 批准号:
11671604 - 财政年份:1999
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Optimizing HPV vaccination programs in Low- and Middle-Income Countries (LMIC) and High-Income Countries (HIC) to reduce inequalities and reach global elimination of cervical cancer: An integrated knowledge translation dynamic-modeling approach
优化中低收入国家 (LMIC) 和高收入国家 (HIC) 的 HPV 疫苗接种计划,以减少不平等并实现全球消除宫颈癌:综合知识转化动态建模方法
- 批准号:
495110 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Operating Grants
The Social Impact of Cervical Cancer on Women and their Children in Uganda
宫颈癌对乌干达妇女及其儿童的社会影响
- 批准号:
495276 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Experiences of early-stage cervical cancer and fertility sparing surgery: an ethnographic and co-creative approach to social and intimate domains
早期宫颈癌和保留生育手术的经验:社会和亲密领域的民族志和共同创造方法
- 批准号:
EP/Y023617/1 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Fellowship
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
- 批准号:
10844859 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
接受免疫治疗和放化疗的局部晚期宫颈癌患者结果的免疫基因组预测因子
- 批准号:
10908093 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
宫颈癌护理点 HPV 16/18/45 DNA 检测
- 批准号:
10896570 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Targeting LOX-1 for MDSC-inhibition therapy against cervical cancer
以 LOX-1 为靶点进行 MDSC 抑制治疗宫颈癌
- 批准号:
23K06666 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Economic Impact of Cervical Cancer on Women and Children in Uganda
宫颈癌对乌干达妇女和儿童的经济影响
- 批准号:
492688 - 财政年份:2023
- 资助金额:
$ 1.6万 - 项目类别:














{{item.name}}会员




